PPARG and inflammatory bowel disease: We have shown that the immune modulatory actions of ESA may be both PPARγ-dependent and PPARγ-independent in mice with experimental IBD, although its effects on disease activity and colonic lesions are dependent on expression of PPARγ by immune and epithelial cells.